N-nitrosoanabasine
N-nitrosoanabasine structure
|
Common Name | N-nitrosoanabasine | ||
|---|---|---|---|---|
| CAS Number | 37620-20-5 | Molecular Weight | 191.230 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 380.2±35.0 °C at 760 mmHg | |
| Molecular Formula | C10H13N3O | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 183.8±25.9 °C | |
| Symbol |
GHS06 |
Signal Word | Danger | |
| Name | (r,s)-n-nitrosoanabasine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 380.2±35.0 °C at 760 mmHg |
| Molecular Formula | C10H13N3O |
| Molecular Weight | 191.230 |
| Flash Point | 183.8±25.9 °C |
| Exact Mass | 191.105865 |
| PSA | 45.56000 |
| LogP | 0.49 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.625 |
| Storage condition | -20°C Freezer |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | T |
| Risk Phrases | 25 |
| Safety Phrases | 45 |
| RIDADR | UN2810 6.1/PG 3 |
| HS Code | 2933990090 |
|
~%
N-nitrosoanabasine CAS#:37620-20-5 |
| Literature: Chemische Berichte, , vol. 65, p. 1126,1128 |
|
~%
N-nitrosoanabasine CAS#:37620-20-5 |
| Literature: Chemische Berichte, , vol. 65, p. 1126,1128 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A.
PLoS ONE 10(3) , e0120252, (2015) Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum (ER) stress adapts tumor cells to the tumor microenvironment and enh... |
|
|
Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone.
Drug Metab. Dispos. 43(2) , 182-9, (2014) Evaluation of drug-drug interaction (DDI) involving circulating inhibitory metabolites of perpetrator drugs has recently drawn more attention from regulatory agencies and pharmaceutical companies. Her... |
|
|
Disparities in child mortality trends: what is the evidence from disadvantaged states in India? the case of Orissa and Madhya Pradesh.
Int J Equity Health 12 , 45, (2013) The Millennium Development Goals prompted renewed international efforts to reduce under-five mortality and measure national progress. However, scant evidence exists about the distribution of child mor... |
| 3-(1-Nitrosopiperidin-2-yl)pyridine |
| 1-nitro-pyrene |
| Pyrene,1-nitro |
| Nitropyrene,Mono-,Di-,Tri-Tetra,isomers |
| 3-Nitropyrene |
| nitropyrene |
| 1-nitropyrne |
| 3-(1-Nitroso-2-piperidinyl)pyridine |
| N-nitrosoanabasine |
| 1-nitroso-anabasine |
| Pyridine, 3-(1-nitroso-2-piperidinyl)- |
| Nitrosoanabasin |
- Shanghai Jizhi Biochemical Technology Co., Ltd
- China
- Product Name: N-nitrosoanabasine
- Price: ￥6988.0/10mg
- Purity: 98.0%
- Stocking Period: Inquiry
- Contact: Liu jia
- Dayang Chem (Hangzhou) Co., Ltd.
- China
- Product Name: (R,S)-1-(3,4-(METHYLENEDIOXY)-6-NITROPHENYL)ETHYLCHLOROFORMATE
- Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
- Purity: 98.0%
- Stocking Period: Inquiry
- Contact: Ms Wang
Get all suppliers and price by the below link: